Besides the suppression of tumor progression and osteoclast development, the results indicated that MSC-derived conditioned medium (CM) and atypical tumor-suppressing proteins inhibited the expression of PDL1 - the target of anti-PD1 immunotherapy 21. Here, CD274 is linked to neoplasm.